Option Care Health (NASDAQ:OPCH) Updates FY 2025 Earnings Guidance

Option Care Health (NASDAQ:OPCH) issued an update on its FY 2025 earnings guidance on Monday morning. The company provided earnings per share guidance of 1.720-1.760 for the period, compared to the consensus earnings per share estimate of 1.640. The company issued revenue guidance of $5.6 billion-$5.7 billion, compared to the consensus revenue estimate of $5.6 billion. Option Care Health also updated its FY 2026 guidance to 1.820-1.920 EPS.

Option Care Health Trading Up 0.8%

Shares of OPCH traded up $0.26 during trading hours on Monday, hitting $32.06. The stock had a trading volume of 1,516,765 shares, compared to its average volume of 1,555,112. The company’s fifty day simple moving average is $30.83 and its 200 day simple moving average is $29.40. Option Care Health has a 12-month low of $24.24 and a 12-month high of $35.53. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.05 and a current ratio of 1.56. The firm has a market cap of $5.09 billion, a P/E ratio of 25.44, a P/E/G ratio of 1.98 and a beta of 0.80.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on OPCH. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Option Care Health from $31.00 to $36.00 and gave the company a “buy” rating in a research report on Tuesday, December 9th. Cowen began coverage on shares of Option Care Health in a research report on Thursday, October 2nd. They set a “hold” rating for the company. Wall Street Zen upgraded Option Care Health from a “hold” rating to a “buy” rating in a report on Saturday. Stephens upgraded Option Care Health to a “strong-buy” rating in a research note on Thursday, December 11th. Finally, Morgan Stanley initiated coverage on Option Care Health in a research report on Friday, October 17th. They issued an “overweight” rating and a $35.00 target price for the company. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $36.27.

Insider Activity at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 38,000 shares of the stock in a transaction dated Monday, November 3rd. The shares were bought at an average cost of $25.98 per share, with a total value of $987,240.00. Following the completion of the acquisition, the director owned 413,390 shares of the company’s stock, valued at approximately $10,739,872.20. This trade represents a 10.12% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.64% of the company’s stock.

Institutional Investors Weigh In On Option Care Health

Several hedge funds have recently bought and sold shares of the business. McIlrath & Eck LLC acquired a new stake in shares of Option Care Health during the 2nd quarter worth about $37,000. Advisory Services Network LLC bought a new position in Option Care Health in the third quarter valued at about $35,000. Caitong International Asset Management Co. Ltd bought a new position in shares of Option Care Health in the 3rd quarter valued at about $38,000. EverSource Wealth Advisors LLC grew its holdings in Option Care Health by 528.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock worth $46,000 after acquiring an additional 1,183 shares during the period. Finally, Quarry LP lifted its stake in Option Care Health by 502.7% in the third quarter. Quarry LP now owns 1,549 shares of the company’s stock valued at $43,000 after buying an additional 1,292 shares during the period. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.